We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+6.04%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$932M
AUM Growth
+$28.1M
(+3.1%)
Cap. Flow
-$18.5M
Cap. Flow
% of AUM
-1.98%
Top 10 Holdings %
Top 10 Hldgs %
34.27%
Holding
222
New
12
Increased
42
Reduced
117
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$3.47M |
| 2 |
American Eagle Outfitters
AEO
|
+$2.72M |
| 3 |
Becton Dickinson
BDX
|
+$2.05M |
| 4 |
RDFN
Redfin
RDFN
|
+$1.31M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$4.58M |
| 2 |
Mastercard
MA
|
+$2.99M |
| 3 |
Biogen
BIIB
|
+$2.95M |
| 4 |
Johnson & Johnson
JNJ
|
+$2.66M |
| 5 |
Autoliv
ALV
|
+$1.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.85% |
| 2 | Technology | 18.2% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 12.07% |
| 5 | Communication Services | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
S&P Global
SPGI
$120B
| $661K | 0.07% |
2,903
-200
| -6% | -$43.7K |
|
|
SGEN
127
DELISTED
Seagen Inc. Common Stock
SGEN
| $657K | 0.07% |
9,500
+350
| +4% | +$24.5K |
|
128
DuPont de Nemours
DD
$19.5B
| $646K | 0.07% |
6,855
-3,238
| -32% | -$387K |
|
|
BLUE
129
DELISTED
bluebird bio
BLUE
| $637K | 0.07% |
386
+3
| +0.8% | +$5.19K |
|
130
Medtronic
MDT
$116B
| $596K | 0.06% |
6,124
-168
| -3% | -$15.3K |
|
131
Vanguard Morningstar Small-Cap Value ETF
VBR
$38B
| $596K | 0.06% |
4,569
-75
| -2% | -$9.75K |
|
132
iShares S&P 500 Growth ETF
IVW
$76.9B
| $576K | 0.06% |
12,852
| – | – |
|
133
Adobe
ADBE
$105B
| $575K | 0.06% |
1,951
+50
| +3% | +$13.9K |
|
134
Regeneron Pharmaceuticals
REGN
$82.1B
| $574K | 0.06% |
1,835
| – | – |
|
135
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.02B
| $566K | 0.06% |
7,100
| – | – |
|
136
American Express
AXP
$230B
| $542K | 0.06% |
4,395
+690
| +19% | +$81K |
|
|
AGN
137
DELISTED
Allergan plc
AGN
| $540K | 0.06% |
3,225
| – | – |
|
138
Sysco
SYY
$40.3B
| $517K | 0.06% |
7,305
| – | – |
|
139
Tesla
TSLA
$1.31T
| $507K | 0.05% |
34,065
-2,190
| -6% | -$34.1K |
|
140
NetApp
NTAP
$38.9B
| $503K | 0.05% |
8,150
-1,000
| -11% | -$67.5K |
|
141
Qualcomm
QCOM
$171B
| $495K | 0.05% |
6,508
-1
| -0% | -$73 |
|
142
Enterprise Products Partners
EPD
$81.8B
| $493K | 0.05% |
17,063
+400
| +2% | +$11.5K |
|
|
WBA
143
DELISTED
Walgreens Boots Alliance
WBA
| $482K | 0.05% |
8,825
-1,050
| -11% | -$55.8K |
|
|
KSU
144
DELISTED
Kansas City Southern
KSU
| $475K | 0.05% |
3,900
+150
| +4% | +$18K |
|
145
iShares Russell 1000 Growth ETF
IWF
$127B
| $443K | 0.05% |
11,268
-1,080
| -9% | -$41.8K |
|
146
Intuit
INTU
$92B
| $432K | 0.05% |
1,652
+49
| +3% | +$12.5K |
|
147
Vanguard Real Estate ETF
VNQ
$38.3B
| $424K | 0.05% |
4,846
-97
| -2% | -$8.49K |
|
148
Target
TGT
$69.2B
| $422K | 0.05% |
4,870
-275
| -5% | -$22.2K |
|
149
Mondelez International
MDLZ
$78.9B
| $405K | 0.04% |
7,521
| – | – |
|
|
CELG
150
DELISTED
Celgene Corp
CELG
| $405K | 0.04% |
4,384
+172
| +4% | +$16.3K |
|
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
NIM
C
Reynders McVeigh Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Reynders McVeigh Capital Management held 222 positions worth $932M, up 3.1% from $904M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Reynders McVeigh Capital Management's Q2 2019 filing shows 12 new, 42 increased, 117 reduced and 9 closed positions. Its largest new stake was Alcon: 59,134 shares worth $3.67M. The largest sale was Novartis, an estimated $4.58M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Technology and Financials.
- Reynders McVeigh Capital Management's largest Q2 2019 buy was Alcon: 59,134 shares worth $3.67M.
- Reynders McVeigh Capital Management added most to American Eagle Outfitters in Q2 2019, an estimated $2.72M increase.
- Reynders McVeigh Capital Management's biggest Q2 2019 reduction was Novartis, cutting an estimated $4.58M.
- Reynders McVeigh Capital Management fully exited Autoliv in Q2 2019, selling an estimated $1.32M.
- Reynders McVeigh Capital Management's ten largest holdings make up 34% of its $932M portfolio in Q2 2019.
- Reynders McVeigh Capital Management opened 12 new positions and closed 9 in Q2 2019.
- Reynders McVeigh Capital Management's portfolio value rose 3.1% quarter-over-quarter to $932M.
Based on Reynders McVeigh Capital Management's 13F filing for Q2 2019, filed 6 Aug 2019.